Detalhe da pesquisa
1.
Contact Days Associated With Cancer Treatments in the CCTG LY.12 Trial.
Oncologist
; 28(9): 799-803, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226534
2.
Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6.
Support Care Cancer
; 31(5): 256, 2023 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37043087
3.
Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12.
Blood
; 126(6): 733-8, 2015 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26109202
4.
ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma.
N Engl J Med
; 366(5): 399-408, 2012 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-22149921
5.
A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma.
Blood
; 128(5): 732-5, 2016 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27338095
6.
A Canadian Prospective Study of Linkage of Randomized Clinical Trial to Cancer and Mortality Registry Data.
Curr Oncol
; 28(2): 1153-1160, 2021 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33800281
7.
Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial.
Curr Oncol
; 28(2): 1256-1261, 2021 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33802634
8.
The conditional survival analysis of relapsed DLBCL after autologous transplant: a subgroup analysis of LY.12 and CORAL.
Blood Adv
; 4(9): 2011-2017, 2020 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32396614
9.
Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12.
Leuk Lymphoma
; 58(1): 64-69, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27266754
10.
Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study.
Leuk Lymphoma
; 58(10): 2319-2327, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28504033
11.
Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.
J Clin Oncol
; 23(21): 4634-42, 2005 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-15837968
12.
Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12.
J Clin Oncol
; 32(31): 3490-6, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25267740
13.
Bortezomib ADDED to R-CVP is safe and effective for previously untreated advanced-stage follicular lymphoma: a phase II study by the National Cancer Institute of Canada Clinical Trials Group.
J Clin Oncol
; 29(25): 3396-401, 2011 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21810681
14.
Phase II study of vandetanib or placebo in small-cell lung cancer patients after complete or partial response to induction chemotherapy with or without radiation therapy: National Cancer Institute of Canada Clinical Trials Group Study BR.20.
J Clin Oncol
; 25(27): 4278-84, 2007 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-17878480
15.
A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7.
Br J Haematol
; 136(2): 203-11, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17233817